Atossa Therapeutics
ATOS
$1.53
Share price
5.01%
Change (1 day)
115.93%
Change (1 year)
Categories
Atossa Therapeutics (ATOS) - Total assets
Total assets on the balance sheet as of September 2023 : $0.10 B
According to Atossa Therapeutics's latest financial reports the company's total assets are $0.10 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Atossa Therapeutics - Total assets on balance sheet (from 2010 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | -12.55% |
| 2021-12-31 | $0.14 B | 229.75% |
| 2020-12-31 | $42.83 M | 195.65% |
| 2019-12-31 | $14.48 M | 23.63% |
| 2018-12-31 | $11.72 M | 43.56% |
| 2017-12-31 | $8.16 M | 96.99% |
| 2016-12-31 | $4.14 M | -33.62% |
| 2015-12-31 | $6.24 M | -46.93% |
| 2014-12-31 | $11.76 M | -2.04% |
| 2013-12-31 | $12 M | 75.93% |
| 2012-12-31 | $6.82 M | 122.21% |
| 2011-12-31 | $3.07 M | 20365.65% |
| 2010-12-31 | $0.01 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $171.96 B | 168,999.76% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $13.95 B | 13,621.42% | 🇺🇸 USA |
 LabCorp LH | $16.53 B | 16,155.47% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | N/A | N/A | 🇺🇸 USA |
 NeoGenomics
NEO | $1.64 B | 1,513.00% | 🇺🇸 USA |
 Enzo Biochem ENZ | $99.07 M | -2.57% | 🇺🇸 USA |